Notable Labs Ltd (NAS:NTBL)
$ 0.8 -0.01 (-1.23%) Market Cap: 7.21 Mil Enterprise Value: 967,000.00 PE Ratio: 0 PB Ratio: 0.48 GF Score: 18/100

Q1 2019 Vascular Biogenics Ltd Earnings Call Transcript

May 15, 2019 / 12:30PM GMT
Operator

Greetings and welcome to the VBL Therapeutics First Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mr. Michael Wood of LifeSci Advisors. Thank you. You may begin.

Michael Wood
LifeSci Advisors - Biotech Investor Relations

Thank you, operator. Good morning and thank you all for participating in today's First Quarter 2019 Results and Corporate Update Conference Call. Leading the call this morning will be Dror Harats, CEO of VBL; and Amos Ron, the Company's CFO.

A press release with the Company's financial results became available earlier this morning and can be found on the Investors page of the Company's website at ir.vblrx.com.

Before we begin, I'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the Safe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot